3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
3
Oropharyngeal Neoplasms
2
Adenocarcinoma
2
Stomatitis
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Recurrence
1
Prostate Adenocarcinoma
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Malignant Liver Neoplasm
1
Lung Neoplasms
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Eyelid Squamous Cell Carcinoma
1
Cholangiocarcinoma
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Breast Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
5
lutetium Lu 177 dotatate
4
Specimen Handling
4
Radiosurgery
3
gallium Ga 68 dotatate
2
Ga(III)-DOTATOC
2
Bevacizumab
2
regorafenib
1
pembrolizumab
1
olaparib
1
neratinib
1
capivasertib
1
cabozantinib
1
brigatinib
1
abemaciclib
1
X-Rays
1
Watchful Waiting
1
Tablets
1
Surveys and Questionnaires
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Protons
1
Proton Therapy
1
Photons
1
Observation
1
ONC206
1
Nivolumab
1
Mental Status and Dementia Tests
1
Lysine
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Meningioma
×
Radiotherapy, Image-Guided
×
90 days
×
Clear all
No trials found.